BWV insider filings
Blue Water Biotech, Inc. — 8 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-01. Screen BWV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BWV between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Blue Water Biotech, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-01 | 4 | Jeremic Vuk — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | Ramdeen Timothy R. — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | Tarsh Simon — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-06-01 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 6,360 @ $0 | EDGAR |
| 2023-05-11 | 4 | Henderson Erin — Chief Business Officer | Grant/award (A): 150,000 | EDGAR |
| 2023-05-11 | 4 | Hernandez Joseph — CEO, Director, 10% owner | Grant/award (A): 150,000 | EDGAR |
| 2023-05-11 | 4 | Garfield Jon — Chief Financial Officer | Grant/award (A): 100,000 | EDGAR |
| 2023-04-12 | 4 | Cincinnati Cornerstone Investors BWV I, LLC — 10% owner Cincinnati Cornerstone Capital LLC | Other (J): 1,200,000 @ $0 | EDGAR |
Recent 8-K events — Blue Water Biotech, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Blue Water Biotech, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298259 (S-1) — latest: Amendment (S-1/A), filed 2026-08-31
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BWV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →